Exhaled carbon monoxide as a new marker of respiratory diseases in children

Journal of Physiology and Pharmacology

Volumn 59, Issue SUPPL. 6, 2008, Pages 9-17

  Babusikova, E ^a   Jesenak, M ^b   Durdik, P ^b   Dobrota, D ^a   Banovcin, P ^b  

^a University Teaching Hospital in Martin   (Slovakia)

^b Physics and Informatics   (Slovakia)

Author keywords

Children; Exhaled breath analysis; Exhaled carbon monoxide; Oxidative stress; Respiratory diseases

Indexed keywords

CARBON DIOXIDE; MALONALDEHYDE; BIOLOGICAL MARKER; CARBON MONOXIDE;

ALLERGIC RHINITIS; ASTHMA; BRONCHUS HYPERREACTIVITY; CARBON DIOXIDE BREATHING; CHRONIC OBSTRUCTIVE LUNG DISEASE; CILIARY DYSKINESIA; CYSTIC FIBROSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; DISEASE EXACERBATION; DISEASE MARKER; EXHALATION; HUMAN; INTERSTITIAL LUNG DISEASE; LIPID PEROXIDATION; PEAK EXPIRATORY FLOW; REVIEW; UPPER RESPIRATORY TRACT INFECTION; CHILD; METABOLISM; RESPIRATORY TRACT ALLERGY; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION;

BIOLOGICAL MARKERS; CARBON MONOXIDE; CHILD; HUMANS; RESPIRATORY HYPERSENSITIVITY; RESPIRATORY TRACT DISEASES; RESPIRATORY TRACT INFECTIONS;

EID: 64549163687     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Tenure R, Merver H, Schmidt R. Microsomal heme oxygenase, characterization of the enzyme. J Biol Chem 1969; 244: 6388-6394.
2. Keyse SM, Tyrrell AM. Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts of UVA radiation, hydrogen peroxide and sodium arsenite. Proc Natl Acad Sci USA 1989; 86: 99-103.
3. Sardana MK, Drummond GS, Sassa S, Kappas A. The potent heme oxygenase inducing action of arsenic and parasiticidal arsenicals. Pharmacology 1981; 23: 247-253.
4. Nath KA, Grande JP, Haggard JJ et al. Oxidative stress and induction of heme oxygenase-1 in the kidney in sickle cell disease. Am J Pathol 2001; 158: 892-903.
5. Paredi P, Leckie MJ, Horvath I et al. Changes in exhaled carbon monoxide and nitric oxide levels following allergen challenge in patients with asthma. Eur Respir J 1999; 13: 48-52.
6. Maines MD, Trakshel GM, Kutty RK. Characterization of two constitutive forms of rat liver microsomal heme oxygenase: Only one molecular species of the enzyme is inducible. J Biol Chem 1986; 261: 411-419.
7. Paredi P, Kharitov SA, Barnes JB. Analysis of expired air for oxidation products. Am J Res Crit Care Med 2002; 166: S31-S37.
8. McCoubrey WK Jr, Huang TJ, Maines MD. Isolation and characterization of a cDNA from the rat brain that encodes hemoprotein heme oxygenase-3. Eur J Biochem 1997; 247: 725-732.
9. Hayashi S, Omata Y, Sakamoto H et al. Characterisation of rat heme oxygenase-3 gene. Implication of processed pseudogenes derived from heme oxygenase-2 gene. Gene 2004; 336: 241-250.
10. Stocker R, Yamamoto Y, McDonagh AF, Glazer AN, Ames BN. Bilirubin is an antioxidant of possible physiological importance. Science 1987; 235: 1043-1046.
11. Baranamo DE, Rao M, Ferris CD, Snyder SH. Bilirubin reductase: A major physiologic cytoprotectant. Proc Natl Acad Sci USA 2002; 99: 16093-16098.
12. Ohrui T, Yasuda H, Yamaya M, Matsiu T, Sasaki H. Transient relief of asthma symptoms during jaundice: A possible beneficial role of bilirubin. J Exp Med 2003; 199: 193-196.
13. Eisenstein RS, Garcia-Mayol D, Pettingell W, Munro HN. Regulation of ferritin and heme oxygenase synthesis in rat fibroblasts by different forms of iron. Proc Natl Acad Sci USA 1991; 88: 688-992.
14. Otterbein LE, Kolls JK, Mantell LL, Cook JL, Alam J, Choi AM. Exogenous administration of heme oxygenase-1 by gene transfer provides protection against hyperoxia-induced lung injury. J Clin Invest 1999; 103: 1047-1054.
15. Otterbein LE, Mantell LL, Choi AM. Carbon monoxide provides protection against hyperoxic lung injury. Am J Physiol Lung Cell Moll Physiol 1999; 276: L688-694
16. Kharitov SA, Barnes PJ. Exhaled markers of pulmonary diseases. Am J Respir Crit Care Med 2001; 163: 1693-1722.
17. Kharitov SA, Barnes PJ. Biomarkers of some pulmonary diseases in exhaled air. Biomarkers 2002; 7: 1-32.
18. Andersson JA, Uddman R, Cardell LO. Carbon monoxide is endogenously produced in the human nose and paranasal sinuses. J Allergy Clin Immunol 2000; 105: 269-273.
19. Paredi P, Biernacki W, Invernizzi G et al. Exhaled carbone monoxide levels in diabetes and correlated with glucose concentration in blood: a new test for monitoring the disease? Chest 1999; 116: 1007-1011.
20. Paredi P, Kharitov SA, Leak D et al. Exhaled ethane is elevated in cystic fibrosis and correlates with carbon monoxide levels and airway obstruction. Am J Respir Crit Med 2000; 161: 1247-1251.
21. Yamaya M, Sekizawa K, Ishizuka S et al. Exhaled carbon monoxide levels during treatment of acute asthma. Eur Respir J 1999; 13: 757-760.
22. Antuni JD, Kharitov SA, Hughes D et al. Increase in exhaled carbon monoxide during exacerbation of cystic fibrosis. Thorax 2000; 55: 138-142.
23. Horvath I, Loukides S, Wodehouse T et al. Increased levels of exhaled carbon monoxide in bronchiectasis: new marker of oxidative stress. Thorax 1998; 53: 867-870.
24. Zayasu K, Sekizawa K, Okinaga S et al. Increased carbon monoxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1997; 156: 1140-1143.
25. Montuschi P, Kharitov SA, Barnes PJ. Exhaled carbone monoxide and nitric oxide in COPD. Chest 2001; 120: 495-502.
26. Martinez FD. Trends in asthma prevalence, admission rates, and asthma deaths. Respir Care 2008; 53: 561-567.
27. Horvath I, Donnelly LE, Kiss A et al. Raised levels of exhaled carbon monoxide are associated with an increased expression of heme oxygenase-1 in airway macrophages in asthma: a new marker of oxidative stress. Thorax 1998; 53: 668-672.
28. Wood LG, Gibson PG, Garg ML. Biomarkers of lipid peroxidation, airway inflammation and asthma. Eur Respir J 2003; 21: 177-186.
29. Lim S, Croneberg D, Fischer A et al. Expression of heme oxygenase isoenzymes 1 and 2 in normal and asthmatic airways - effect of inhaled corticosteroids. Am J Respir Crit Care Med 2000; 162: 1912-1918.
30. Yamaya M, Sekizawa K, Ishizuka S et al. Exhaled carbon monoxide in exhaled air of subjects with upper respiratory tract infections. Am J Respir Crit Care Med 1998; 158: 311-314.
31. Kharitov SA. Exhaled markers of inflammatory lung diseases: ready for routine monitoring? Swiss Med Wkly 2004; 134: 175-192.
32. Momma M, Yamaya M, Sekizawa K et al. Increased carbon monoxide in exhaled air of patients with seasonal allergic rhinitis. Clin Exp Allergy1999; 29: 1537-1541.
33. Kharitonov SA. Exhaled nitric oxide and carbon monoxide in respiratory diseases other than asthma. Eur Respir J 1999; 9: 223-226.
34. Antuni JD, Ward S, Cramer DS et al. Exhaled carbon monoxide may be a marker of deterioration of lung function in cryptogenic fibrosing alveolitis and scleroderma. Am J Respir Crit Care Med 1999; 159: A51 (Abstract).
35. Antuni JD, Ward S, Cramer DS et al. Uptake and elimination of exhaled carbon monoxide in patients with interstitial lung disease is related to the degree of impairment of carbon monoxide diffusion capacity [abstract]. Am J Respir Crit Care Med 1999; 159: A86.
36. Paredi P, Kharitonov SA, Loukides S et al. Exhaled nitric oxide is increased in active fibrosing alveolitis. Chest 1999; 115: 1352-1356.